Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leveling the playing field.

Kian-Huat Lim1, Christopher M Counter

  • 1Department of Pharmacology and Cancer Biology, Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA.

Molecular Cell
|August 26, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blockade of Tumor TAK1 Induces DNA Damage and Immunogenic cGAS-STING Pathway Activation in Pancreatic Cancer.

Gastroenterology·2026
Same author

Adaptive Salvage Stereotactic Radiation for Locoregional Recurrence of Pancreatic Adenocarcinoma After Surgery.

Practical radiation oncology·2026
Same author

The Impact of Endoscopic Ultrasound and Multidisciplinary Team Evaluation on the Management of Pancreatic Cystic Lesions.

United European gastroenterology journal·2026
Same author

Prolonged KRAS-MAPK Inhibition Induces Interferon Signaling That Promotes Cell State Transition and Confers Therapeutic Vulnerabilities.

Cancer research·2026
Same author

Editorial Expression of Concern: Creation of human tumour cells with defined genetic elements.

Nature·2026
Same author

Profiling KRAS mutations in whole blood by error-corrected maximum depth sequencing.

NPJ precision oncology·2026
Same journal

Thyroid cancer-associated EZH1 Q571R mutation drives chromatin compaction and H3K27me3 invasion into active chromatin.

Molecular cell·2026
Same journal

Genome-wide rotational and translational phasing of nucleosomes with human transcription factors.

Molecular cell·2026
Same journal

Spliceosomal proofreading factors safeguard 3' splice-site fidelity and prevent proteotoxicity and inflammation.

Molecular cell·2026
Same journal

Cytosolic EZH2-IMPDH2 complexes regulate melanoma progression and metastasis via GTP.

Molecular cell·2026
Same journal

A bacterial reverse transcriptase: Protein-templated DNA synthesis fuels antiviral immunity.

Molecular cell·2026
Same journal

Tweezing apart ribosome heterogeneity.

Molecular cell·2026
See all related articles

Murine cells are more susceptible to transformation than human cells, according to a study using a genetically malleable model system. Researchers also identified potential cell type-specific constraints on human cell transformation.

Area of Science:

  • Cell biology
  • Genetics
  • Cancer research

Background:

  • Understanding cellular transformation is crucial for cancer research.
  • Previous studies have suggested differences in transformation susceptibility between species.
  • A direct comparison model is needed to clarify these differences.

Purpose of the Study:

  • To definitively compare the transformation susceptibility of mouse (murine) and human cells.
  • To investigate potential cell type-specific factors influencing human cell transformation.

Main Methods:

  • Utilized a genetically malleable model system enabling direct comparison of human and mouse cells.
  • Employed comparative analyses to assess transformation efficiency across cell types.

Related Experiment Videos

Main Results:

  • Provided conclusive evidence that murine cells are more readily transformed than human cells.
  • Discovered potential cell type-specific constraints affecting the transformation of human cells.

Conclusions:

  • The study resolves ambiguity regarding species-specific differences in cellular transformation.
  • Findings suggest that human cell transformation may be regulated by cell type-specific mechanisms, impacting cancer development research.